sch 34826 has been researched along with n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine in 1 studies
Studies (sch 34826) | Trials (sch 34826) | Recent Studies (post-2010) (sch 34826) | Studies (n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine) | Trials (n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine) | Recent Studies (post-2010) (n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine) |
---|---|---|---|---|---|
31 | 2 | 0 | 225 | 0 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Innes, DG; Kavaliers, M | 1 |
1 other study(ies) available for sch 34826 and n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine
Article | Year |
---|---|
Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826.
Topics: Analgesia; Analgesics; Animals; Dioxolanes; Dipeptides; Enkephalin, Leucine; Female; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neprilysin; Peromyscus; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Restraint, Physical; Sex Characteristics; Stress, Psychological | 1993 |